Welcome to our dedicated page for Banco Bradesco SEC filings (Ticker: BBDO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Banco Bradesco S.A.'s SEC filings document foreign-issuer reporting for a Brazilian bank with ADRs representing common shares. Form 6-K reports include management analysis, IFRS consolidated financial statements, economic commentary, recurring income measures, net interest income, funding sources, loan-portfolio indicators, fee and commission income, operating expenses, and Bradesco Seguros insurance results.
The filings also cover Basel guidance and capital indicators, customer strategy, sustainability, digital operations, international activities, shareholder returns, and comparative accounting presentation under Brazilian and IFRS frameworks. Ownership disclosures report securities and derivatives activity for controllers, directors, executive officers, audit committee members, and other corporate bodies.
Banco Bradesco S.A. filed a Form 6-K reporting the consolidated summary voting map from its distance voting ballot for a Special Shareholders’ Meeting scheduled for March 31, 2026 at 4:00 p.m. The meeting will decide on the partial spin-off of Bradseg Participações S.A. and related steps.
Remote voting instructions show very strong advance support for all five resolutions, including approval of the spin-off protocol and justification, ratification of KPMG as appraiser, the appraisal report itself, the Bradseg partial spin-off, and authorization for officers to implement the transaction, with roughly 450 million shares voting in favor and very small numbers voting against or abstaining on each item.
Banco Bradesco S.A. filed a Form 6-K reporting the consolidated summary voting map from its distance voting ballot for a Special Shareholders’ Meeting scheduled for March 31, 2026 at 4:00 p.m. The meeting will decide on the partial spin-off of Bradseg Participações S.A. and related steps.
Remote voting instructions show very strong advance support for all five resolutions, including approval of the spin-off protocol and justification, ratification of KPMG as appraiser, the appraisal report itself, the Bradseg partial spin-off, and authorization for officers to implement the transaction, with roughly 450 million shares voting in favor and very small numbers voting against or abstaining on each item.
Banco Bradesco S.A. reports stronger 2025 results under IFRS, with consolidated net income of R$23.9 billion, up from R$17.5 billion in 2024. Earnings per common share reached R$2.13 and preferred share earnings R$2.35, supported by higher net interest income and insurance results.
Total assets rose to R$2.33 trillion, with the expanded loan portfolio at R$1.09 trillion, an 11.0% increase versus December 2024, and total deposits at R$728.0 billion, up 12.2%. Securities totaled R$925.4 billion, growing 19.4%, while allowance for expanded loans declined 2.6% to R$56.8 billion.
Shareholders’ equity attributable to the parent reached R$178.4 billion, Tier I capital stood at 13.2%, and interest on shareholders’ equity was R$14.5 billion (gross), a 36.4% year-on-year increase. Management highlights accelerated technology and AI adoption, stronger sustainability commitments and diversity metrics, and reiterates a minimum dividend policy of 30% of net income.
Banco Bradesco S.A. reports stronger 2025 results under IFRS, with consolidated net income of R$23.9 billion, up from R$17.5 billion in 2024. Earnings per common share reached R$2.13 and preferred share earnings R$2.35, supported by higher net interest income and insurance results.
Total assets rose to R$2.33 trillion, with the expanded loan portfolio at R$1.09 trillion, an 11.0% increase versus December 2024, and total deposits at R$728.0 billion, up 12.2%. Securities totaled R$925.4 billion, growing 19.4%, while allowance for expanded loans declined 2.6% to R$56.8 billion.
Shareholders’ equity attributable to the parent reached R$178.4 billion, Tier I capital stood at 13.2%, and interest on shareholders’ equity was R$14.5 billion (gross), a 36.4% year-on-year increase. Management highlights accelerated technology and AI adoption, stronger sustainability commitments and diversity metrics, and reiterates a minimum dividend policy of 30% of net income.
Banco Bradesco held combined Special and Annual Shareholders’ Meetings on March 10, 2026, approving a R$6,670,000,000.00 capital increase, from R$87,100,000,000.00 to R$93,770,000,000.00, by capitalizing the “Profit Reserves - Legal Reserve” without issuing new shares and updating its Bylaws accordingly.
Shareholders approved 2025 net income of R$24,549,088,823.36 and its allocation, including R$14,499,272,511.68 in interest on shareholders’ equity, of which R$7,599,272,511.68 has been paid and R$6,900,000,000.00 will be paid by July 31, 2026. They also elected an 11‑member Board of Directors and a three‑member Fiscal Council, authorized management profit sharing, and set 2026 global management remuneration at up to R$910,000,000.00 plus a R$36,952,000.00 pension plan fund, as well as fixed monthly fees of R$46,150.00 for each effective Fiscal Council member and R$6,000.00 for each alternate.
Banco Bradesco held combined Special and Annual Shareholders’ Meetings on March 10, 2026, approving a R$6,670,000,000.00 capital increase, from R$87,100,000,000.00 to R$93,770,000,000.00, by capitalizing the “Profit Reserves - Legal Reserve” without issuing new shares and updating its Bylaws accordingly.
Shareholders approved 2025 net income of R$24,549,088,823.36 and its allocation, including R$14,499,272,511.68 in interest on shareholders’ equity, of which R$7,599,272,511.68 has been paid and R$6,900,000,000.00 will be paid by July 31, 2026. They also elected an 11‑member Board of Directors and a three‑member Fiscal Council, authorized management profit sharing, and set 2026 global management remuneration at up to R$910,000,000.00 plus a R$36,952,000.00 pension plan fund, as well as fixed monthly fees of R$46,150.00 for each effective Fiscal Council member and R$6,000.00 for each alternate.
Banco Bradesco S.A. filed a detailed report on securities dealings by its controlling group, management, treasury and related entities for February 2026. The controlling shareholders’ position remained unchanged at 3,811,582,439 common shares and 121,067,106 non-voting shares.
Board members and their families held 17,135,704 common and 43,777,202 non-voting shares at month-end, after modest changes. Executive officers and their families made numerous small trades in non-voting shares, with a slight reduction to 10,719,646 non-voting shares at month-end.
The most notable movement came from the treasury, which bought 3,150,000 common shares for R$ 55,731,768.34 and 3,150,000 non-voting shares for R$ 64,289,110.39 on 6 February, increasing treasury holdings to 10,650,000 shares of each class. Most controlled and related companies reported no share or derivative operations in the period.
Banco Bradesco S.A. filed a detailed report on securities dealings by its controlling group, management, treasury and related entities for February 2026. The controlling shareholders’ position remained unchanged at 3,811,582,439 common shares and 121,067,106 non-voting shares.
Board members and their families held 17,135,704 common and 43,777,202 non-voting shares at month-end, after modest changes. Executive officers and their families made numerous small trades in non-voting shares, with a slight reduction to 10,719,646 non-voting shares at month-end.
The most notable movement came from the treasury, which bought 3,150,000 common shares for R$ 55,731,768.34 and 3,150,000 non-voting shares for R$ 64,289,110.39 on 6 February, increasing treasury holdings to 10,650,000 shares of each class. Most controlled and related companies reported no share or derivative operations in the period.
Banco Bradesco S.A. provides its 2026 corporate and reporting calendar. The bank plans to release quarterly information for 2026 on 05/05/2026 (1st quarter), 07/29/2026 (2nd quarter) and 10/28/2026 (3rd quarter).
The annual shareholders’ meeting materials, including the management proposal and call notice, are scheduled to be sent on 02/06/2026, with the meeting set for 03/10/2026. A videoconference with analysts to discuss 3rd-quarter 2026 results is planned for 10/29/2026. The text also reiterates standard cautionary language about forward-looking statements and related risks and uncertainties.
Banco Bradesco S.A. provides its 2026 corporate and reporting calendar. The bank plans to release quarterly information for 2026 on 05/05/2026 (1st quarter), 07/29/2026 (2nd quarter) and 10/28/2026 (3rd quarter).
The annual shareholders’ meeting materials, including the management proposal and call notice, are scheduled to be sent on 02/06/2026, with the meeting set for 03/10/2026. A videoconference with analysts to discuss 3rd-quarter 2026 results is planned for 10/29/2026. The text also reiterates standard cautionary language about forward-looking statements and related risks and uncertainties.
Banco Bradesco S.A. called an Extraordinary General Meeting for March 31, 2026 at 4:00 p.m., to be held exclusively in digital format. Shareholders will vote on approving the partial spin-off of Bradseg Participações S.A., with the spun-off net assets absorbed by Bradesco.
This spin-off is part of a broader business combination involving Bradesco Gestão de Saúde S.A. and Odontoprev S.A., with the goal of unifying Bradesco’s health-segment equity interests in Odontoprev. After all stages are completed, Odontoprev is expected to consolidate Bradesco’s healthcare ecosystem, simplifying the corporate structure and potentially improving administrative efficiency.
Banco Bradesco S.A. called an Extraordinary General Meeting for March 31, 2026 at 4:00 p.m., to be held exclusively in digital format. Shareholders will vote on approving the partial spin-off of Bradseg Participações S.A., with the spun-off net assets absorbed by Bradesco.
This spin-off is part of a broader business combination involving Bradesco Gestão de Saúde S.A. and Odontoprev S.A., with the goal of unifying Bradesco’s health-segment equity interests in Odontoprev. After all stages are completed, Odontoprev is expected to consolidate Bradesco’s healthcare ecosystem, simplifying the corporate structure and potentially improving administrative efficiency.
Banco Bradesco S.A. is restructuring its healthcare businesses by consolidating them under Odontoprev S.A., which will be renamed Bradsaúde S.A.. Bradseg will be partially spun off so that Bradesco directly holds shares of Odontoprev and Bradesco Gestão de Saúde (BGS), and Odontoprev will merge the shares of BGS, making BGS its wholly owned subsidiary. Bradesco will receive 2,378,374,445 new Odontoprev shares in exchange for all BGS shares, based on an exchange ratio of 0.17998067486 Odontoprev share per BGS share. After the transaction, Bradesco will own 91.35% of Odontoprev’s total and voting capital and current Odontoprev shareholders will hold 8.65%, excluding treasury shares and any withdrawal effects. Odontoprev’s dental operations and related assets will be contributed to Mediservice, and Odontoprev/Bradsaúde will act solely as a holding company for Bradesco’s healthcare businesses. The companies highlight expected commercial synergies, broader healthcare scope, and potential Basel ratio benefits for Bradesco, while noting that the spin-off itself does not change Bradesco’s share capital and does not create withdrawal rights for Bradesco or Bradseg shareholders.
Banco Bradesco S.A. is restructuring its healthcare businesses by consolidating them under Odontoprev S.A., which will be renamed Bradsaúde S.A.. Bradseg will be partially spun off so that Bradesco directly holds shares of Odontoprev and Bradesco Gestão de Saúde (BGS), and Odontoprev will merge the shares of BGS, making BGS its wholly owned subsidiary. Bradesco will receive 2,378,374,445 new Odontoprev shares in exchange for all BGS shares, based on an exchange ratio of 0.17998067486 Odontoprev share per BGS share. After the transaction, Bradesco will own 91.35% of Odontoprev’s total and voting capital and current Odontoprev shareholders will hold 8.65%, excluding treasury shares and any withdrawal effects. Odontoprev’s dental operations and related assets will be contributed to Mediservice, and Odontoprev/Bradsaúde will act solely as a holding company for Bradesco’s healthcare businesses. The companies highlight expected commercial synergies, broader healthcare scope, and potential Basel ratio benefits for Bradesco, while noting that the spin-off itself does not change Bradesco’s share capital and does not create withdrawal rights for Bradesco or Bradseg shareholders.
Banco Bradesco S.A. responded to a request from the Brazilian securities regulator about media comments on its agribusiness growth targets. The article cited a projection of 15%–20% growth in the direct agribusiness portfolio in 2026, on a base then estimated at R$ 120 billion.
Bradesco explains that these rural credit projections are already included in its previously released guidance, so it did not see a need to publish a separate material fact. The bank emphasizes that these projections are not guarantees of future performance and are subject to risks and uncertainties.
It also cites applicable Brazilian regulations, including Resolution No. 44/2021, and reiterates that any material facts or changes in projections will be disclosed to the market in a timely manner through the appropriate channels.
Banco Bradesco S.A. responded to a request from the Brazilian securities regulator about media comments on its agribusiness growth targets. The article cited a projection of 15%–20% growth in the direct agribusiness portfolio in 2026, on a base then estimated at R$ 120 billion.
Bradesco explains that these rural credit projections are already included in its previously released guidance, so it did not see a need to publish a separate material fact. The bank emphasizes that these projections are not guarantees of future performance and are subject to risks and uncertainties.
It also cites applicable Brazilian regulations, including Resolution No. 44/2021, and reiterates that any material facts or changes in projections will be disclosed to the market in a timely manner through the appropriate channels.